IN8bio, Inc.INABNASDAQ
LOADING
|||
Cash Flow Under Pressure
Below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-24.25M
↓ 61% below average
Average (6y)
$-15.09M
Historical baseline
Range
High:$-3.53M
Low:$-27.83M
CAGR
+37.9%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-24.25M | -1.3% |
| 2023 | $-23.94M | +14.0% |
| 2022 | $-27.83M | -101.4% |
| 2021 | $-13.82M | -93.7% |
| 2020 | $-7.13M | -39.0% |
| 2019 | $-5.13M | -45.5% |
| 2018 | $-3.53M | - |